Amarin Corporation PLC (AMRN NASDAQ) stock market data APIs
$13.234
-0.23(-1.7%)
as of June 11, 2025
Try our APIs with
free plan!
Amarin Corporation PLC Financial Data Overview
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
Prev. Close
13.234
Open
13.007
High
14.6439
Low
12.753
52 wk Range
7.08-16.4
Market Cap
274 M
Shares Outstanding
20 707 K
Revenue
214 M
EPS
-0.4
Beta
0.718
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amarin Corporation PLC data using free add-ons & libraries
Get Amarin Corporation PLC Fundamental Data
Amarin Corporation PLC Fundamental data includes:
- Net Revenue: 214 M
- EBITDA: -55 514 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-18
- EPS/Forecast: -0.4
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amarin Corporation PLC News
New
Best Momentum Stocks to Buy for June 10th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 10th: Amarin Corporation plc AMRN: This pharmaceuticals company has a Zacks Rank #1 and w...
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has GSK (GSK) been one of those stocks this year? A quick glance...
Standex International Corp (SXI) Q3 2025 Earnings Call Highlights: Record Margins and Strategic ...
Total Revenue: Increased 17.2% year on year to $207.8 million. Adjusted Gross Margin: Record 42.3%, up 230 basis points year on year. Adjusted Operating Margin: Record 19.4%, up 280 basis points year ...
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
-- Nasdaq Compliance Follows ADS Ratio Change to Secure Company’s Public Listing -- -- Amarin Remains Focused on Maximizing the Global Value of VASCEPA/VAZKEPA – DUBLIN and BRIDGEWATER, N.J., Ap...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
